This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Theravance Biopharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.065. Theravance Biopharma's 10-Year median PS Ratio is 17.1831. Therefore, the Median PS Value for today is $18.30.
As of today (2024-04-18), Theravance Biopharma's share price is $9.21. Theravance Biopharma's Median PS Value is $18.30. Therefore, Theravance Biopharma's Price to Median PS Value for today is 0.50.
The historical rank and industry rank for Theravance Biopharma's Median PS Value or its related term are showing as below:
TBPH'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.5 Med: 0.61 Max: 0.61
Current: 0.5
During the past 12 years, the highest Price to Median PS Value of Theravance Biopharma was 0.61. The lowest was 0.50. And the median was 0.61.
TBPH's Price-to-Median-PS-Value is ranked better than 58.14% of 258
companies
in the Biotechnology industry
Industry Median: 0.655
vs TBPH: 0.50
Theravance Biopharma Median PS Value Historical Data
The historical data trend for Theravance Biopharma's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Theravance Biopharma Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Median PS Value
-
-
-
-
18.30
Theravance Biopharma Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Median PS Value
-
-
-
-
18.30
Competitive Comparison
For the Biotechnology subindustry, Theravance Biopharma's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Theravance Biopharma Price-to-Median-PS-Value Distribution
For the Biotechnology industry and Healthcare sector, Theravance Biopharma's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Theravance Biopharma's Price-to-Median-PS-Value falls into.
Theravance Biopharma Median PS Value Calculation
Theravance Biopharma's Median PS Value for today is calculated as
10-Year Median PS Ratio is 17.1831.
Theravance Biopharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.065.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theravance Biopharma (NAS:TBPH) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Theravance Biopharma's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
9.21
/
18.30
=
0.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theravance Biopharma Median PS Value Related Terms
Thank you for viewing the detailed overview of Theravance Biopharma's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Theravance Biopharma (Theravance Biopharma) Business Description
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBPH has been successfully added to your 